冠状动脉轻度狭窄对非阻塞性冠状动脉胸痛患者冠状动脉血流储备的影响

肖双, 李昭屏, 陈少敏, 等. 冠状动脉轻度狭窄对非阻塞性冠状动脉胸痛患者冠状动脉血流储备的影响[J]. 临床心血管病杂志, 2024, 40(7): 536-540. doi: 10.13201/j.issn.1001-1439.2024.07.006
引用本文: 肖双, 李昭屏, 陈少敏, 等. 冠状动脉轻度狭窄对非阻塞性冠状动脉胸痛患者冠状动脉血流储备的影响[J]. 临床心血管病杂志, 2024, 40(7): 536-540. doi: 10.13201/j.issn.1001-1439.2024.07.006
XIAO Shuang, LI Zhaoping, CHEN Shaomin, et al. Effect of mild coronary stenosis on coronary flow reserve in patients with chest pain and non-obstructive coronary artery disease[J]. J Clin Cardiol, 2024, 40(7): 536-540. doi: 10.13201/j.issn.1001-1439.2024.07.006
Citation: XIAO Shuang, LI Zhaoping, CHEN Shaomin, et al. Effect of mild coronary stenosis on coronary flow reserve in patients with chest pain and non-obstructive coronary artery disease[J]. J Clin Cardiol, 2024, 40(7): 536-540. doi: 10.13201/j.issn.1001-1439.2024.07.006

冠状动脉轻度狭窄对非阻塞性冠状动脉胸痛患者冠状动脉血流储备的影响

详细信息

Effect of mild coronary stenosis on coronary flow reserve in patients with chest pain and non-obstructive coronary artery disease

More Information
  • 目的 探讨冠状动脉(冠脉)轻度狭窄对非阻塞性冠脉胸痛患者冠脉血流储备(CFR)的影响。方法 回顾性分析340例由影像学检查明确冠脉狭窄<50%的胸痛患者,并行三磷酸腺苷负荷下经胸多普勒超声测定左前降支的CFR。根据CFR结果将患者分为CFR<2.5组(84例)和CFR≥2.5组(256例),比较两组患者的临床资料、冠脉轻度狭窄比例及超声心动图参数,并分析CFR下降的影响因素。结果 单因素分析显示,CFR<2.5组年龄、收缩压、女性比例、高血压病史比例、冠脉轻度狭窄比例均高于CFR≥2.5组(均P<0.05),BMI、低密度脂蛋白胆固醇(LDL-C)、甘油三酯(TG)值均低于CFR≥2.5组(均P<0.05)。Logistic回归分析结果显示,冠脉轻度狭窄(OR=1.995,95%CI:1.060~3.755,P=0.032)、年龄(OR=1.085,95%CI:1.047~1.124,P<0.01)、收缩压(OR=1.020,95%CI:1.000~1.040,P=0.048)均是CFR降低的独立影响因素。结论 冠脉轻度狭窄、年龄及收缩压是非阻塞性冠脉胸痛患者CFR下降的独立影响因素。
  • 加载中
  • 表 1  两组患者临床资料比较

    Table 1.  Clinical data 例(%), X±S, M(P25, P75)

    项目 CFR<2.5组(84例) CFR≥2.5组(256例) t/χ2/Z P
    女性 62(73.81) 148(57.81) 6.854 0.009
    年龄/岁 66.06±7.61 58.65±9.52 6.484 <0.001
    BMI/(kg/m2) 24.61±3.36 25.67±3.34 -2.595 0.010
    心率/(次/min) 65.86±10.38 65.71±9.16 0.126 0.900
    血压/mmHg
      收缩压 136.51±13.83 130.11±16.34 3.230 0.001
      舒张压 74.92±8.40 75.80±10.22 -0.714 0.476
    既往史
      高血压病史 61(72.62) 145(56.64) 6.762 0.009
      吸烟史 14(16.67) 58(22.66) 2.472 0.291
      糖尿病史 19(22.62) 48(18.75) 0.598 0.439
    生化指标
      TC/(mmol/L) 4.22±0.84 4.45±0.97 -1.922 0.055
      HDL-C/(mmol/L) 1.19±0.29 1.14±0.26 1.807 0.072
      LDL-C/(mmol/L) 2.41±0.70 2.63±0.83 -2.198 0.029
      TG/(mmol/L) 1.26(0.88,1.77) 1.47(1.10,2.09) -2.491 0.013
      空腹血糖/(mmol/L) 5.52±1.41 5.53±1.52 -0.085 0.932
    下载: 导出CSV

    表 2  两组患者超声心动图参数比较

    Table 2.  Echocardiographic parameters X±S, M(P25, P75)

    项目 CFR<2.5组(84例) CFR≥2.5组(256例) t/Z P
    LAD/mm 33.86±4.20 34.19±4.04 -0.643 0.521
    LVEDD/mm 44.58±7.43 44.59±8.07 -0.010 0.992
    LVMI/(g/m2) 72.98(61.49,84.07) 72.35(62.69,83.59) -0.034 0.973
    LVEF/% 71.00(66.00,74.00) 71.00(66.00,74.00) -0.137 0.891
    E/E’ 7.75(5.98,8.73) 7.00(5.70,8.50) -1.532 0.126
    1 mmHg=0.133 kPa。
    下载: 导出CSV

    表 3  按年龄分层后两组患者超声心动图参数比较

    Table 3.  Echocardiographic parameters in patients stratified by age X±S, M(P25, P75)

    项目 CFR<2.5组(84例) CFR≥2.5组(256例) t/Z P
    年龄<60岁(151例)
      LAD/mm 32.91±3.95 34.22±4.29 -1.227 0.222
      LVEDD/mm 44.20±10.05 44.47±8.49 -0.124 0.902
      LVMI/(g/m2) 72.14(54.35,88.87) 71.78(61.52,71.78) -0.287 0.774
      LVEF/% 70.50(61.75,73.25) 71.00(65.75,74.00) -0.466 0.641
      E/E’ 7.00(5.60,8.80) 7.00(5.53,8.40) -0.471 0.638
    年龄≥60岁(189例)
      LAD/mm 34.15±4.29 34.16±3.78 -0.021 0.983
      LVEDD/mm 44.69±6.61 44.72±7.64 -0.026 0.979
      LVMI/(g/m2) 73.27(64.57,73.27) 72.82(65.01,72.82) -0.308 0.758
      LVEF/% 71.00(67.00,74.00) 71.00(67.75,75.00) -0.335 0.737
      E/E’ 7.80(6.00,8.70) 7.00(5.80,8.80) -1.136 0.256
    下载: 导出CSV

    表 4  两组患者冠脉狭窄情况比较

    Table 4.  The degree of coronary artery stenosis 例(%)

    项目 CFR<2.5组(84例) CFR≥2.5组(256例) χ2 P
    冠脉轻度狭窄 27(32.14) 39(15.23) 11.559 0.001
    左前降支轻度狭窄 22(81.48) 31(79.49) 0.040 0.841
    下载: 导出CSV

    表 5  非阻塞性冠脉胸痛患者CFR下降的影响因素

    Table 5.  The influencing factors of CFR decrease in patients with non-obstructive coronary chest pain

    影响因素 β SE Wald P OR 95%CI
    性别(女性) 0.406 0.316 1.654 0.198 1.501 0.808~2.789
    年龄 0.081 0.018 20.608 < 0.010 1.085 1.047~1.124
    BMI -0.066 0.044 2.214 0.137 0.936 0.859~1.021
    收缩压 0.020 0.010 3.918 0.048 1.020 1.000~1.040
    LDL-C -0.254 0.185 1.885 0.170 0.776 0.540~1.115
    TG -0.277 0.170 2.647 0.104 0.758 0.543~1.058
    冠脉轻度狭窄 0.691 0.323 4.576 0.032 1.995 1.060~3.755
    下载: 导出CSV
  • [1]

    Kaski JC, Crea F, Gersh BJ, et al. Reappraisal of ischemic heart disease[J]. Circulation, 2018, 138(14): 1463-1480. doi: 10.1161/CIRCULATIONAHA.118.031373

    [2]

    Schroder J, Prescott E. Doppler echocardiography assessment of coronary microvascular function in patients with angina and no obstructive coronary artery disease[J]. Front Cardiovasc Med, 2021, 8: 723542. doi: 10.3389/fcvm.2021.723542

    [3]

    Vegsundvåg J, Holte E, Wiseth R, et al. Coronary flow velocity reserve in the three main coronary arteries assessed with transthoracic Doppler: a comparative study with quantitative coronary angiography[J]. J Am Soc Echocardiogr, 2011, 24(7): 758-767. doi: 10.1016/j.echo.2011.03.010

    [4]

    Kakuta K, Dohi K, Yamada T, et al. Detection of coronary artery disease using coronary flow velocity reserve by transthoracic Doppler echocardiography versus multidetector computed tomography coronary angiography: influence of calcium score[J]. J Am Soc Echocardiogr, 2014, 27(7): 775-785. doi: 10.1016/j.echo.2014.02.012

    [5]

    李卫虹, 李翠萍, 李昭屏, 等. ATP负荷超声心动图检测冠状动脉血流储备对诊断冠状动脉狭窄的价值[J]. 中华医学杂志, 2013, 93(6): 432-435. doi: 10.3760/cma.j.issn.0376-2491.2013.06.010

    [6]

    Taron J, Foldyna B, Mayrhofer T, et al. Risk stratification with the use of coronary computed tomographic angiography in patients with nonobstructive coronary artery disease[J]. JACC Cardiovasc Imaging, 2021, 14(11): 2186-2195. doi: 10.1016/j.jcmg.2021.03.019

    [7]

    杜兰芳, 李昭屏, 李丹, 等. 血压控制水平对高血压患者冠状动脉血流储备的影响[J]. 中华心血管病杂志, 2016, 44(5): 421-425. doi: 10.3760/cma.j.issn.0253-3758.2016.05.011

    [8]

    Crea F, Montone RA, Rinaldi R. Pathophysiology of coronary microvascular dysfunction[J]. Circ J, 2022, 86(9): 1319-1328. doi: 10.1253/circj.CJ-21-0848

    [9]

    Morrone D, Gentile F, Aimo A, et al. Perspectives in noninvasive imaging for chronic coronary syndromes[J]. Int J Cardiol, 2022, 365: 19-29. doi: 10.1016/j.ijcard.2022.07.038

    [10]

    Al-Mohaissen MA. Echocardiographic assessment of primary microvascular angina and primary coronary microvascular dysfunction[J]. Trends Cardiovasc Med, 2023, 33(6): 369-383. doi: 10.1016/j.tcm.2022.02.007

    [11]

    Gould KL, Lipscomb K. Effects of coronary stenoses on coronary flow reserve and resistance[J]. Am J Cardiol, 1974, 34(1): 48-55. doi: 10.1016/0002-9149(74)90092-7

    [12]

    Kranidis AI, Patsilinakos S, Filippatos G, et al. Non-invasive evaluation of coronary reserve. Assessment of coronary reserve in patients with coronary artery disease by transesophageal-Doppler echocardiography[J]. Int J Cardiol, 1999, 68(1): 107-113. doi: 10.1016/S0167-5273(98)00333-7

    [13]

    Mygind ND, Michelsen MM, Pena A, et al. Coronary microvascular function and cardiovascular risk factors in women with angina pectoris and No obstructive coronary artery disease: the iPOWER study[J]. J Am Heart Assoc, 2016, 5(3): e003064. doi: 10.1161/JAHA.115.003064

    [14]

    Padro T, Manfrini O, Bugiardini R, et al. ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on'coronary microvascular dysfunction in cardiovascular disease'[J]. Cardiovasc Res, 2020, 116(4): 741-755. doi: 10.1093/cvr/cvaa003

    [15]

    Bove KB, Michelsen MM, Schroder J, et al. Impaired coronary flow velocity reserve is associated with cardiovascular risk factors but not with angina symptoms[J]. Open Heart, 2021, 8(1): e001486. doi: 10.1136/openhrt-2020-001486

    [16]

    Kei CY, Singh K, Dautov RF, et al. Coronary"microvascular dysfunction": evolving understanding of pathophysiology, clinical implications, and potential therapeutics[J]. Int J Mol Sci, 2023, 24(14): 11287. doi: 10.3390/ijms241411287

    [17]

    Tracy EP, Hughes W, Beare JE, et al. Aging-induced impairment of vascular function: mitochondrial redox contributions and physiological/clinical implications[J]. Antioxid Redox Signal, 2021, 35(12): 974-1015. doi: 10.1089/ars.2021.0031

    [18]

    Faria D, Mejia-Renteria H, Lee JM, et al. Age-related changes in the coronary microcirculation influencing the diagnostic performance of invasive pressure-based indices and long-term patient prognosis[J]. Catheter Cardiovasc Interv, 2022, 100(7): 1195-1205. doi: 10.1002/ccd.30445

    [19]

    Olic JJ, Baessler A, Fischer M. Chest pain and cardiovascular diseases in women: Diagnostics and treatment[J]. Herz, 2023, 48(6): 487-498. doi: 10.1007/s00059-023-05215-0

    [20]

    Bajaj NS, Osborne MT, Gupta A, et al. Coronary microvascular dysfunction and cardiovascular risk in obese patients[J]. J Am Coll Cardiol, 2018, 72(7): 707-717. doi: 10.1016/j.jacc.2018.05.049

  • 加载中
计量
  • 文章访问数:  215
  • 施引文献:  0
出版历程
收稿日期:  2024-02-25
刊出日期:  2024-07-13

返回顶部

目录